Frequently Asked Questions About Biogen Inc (BIIB) Stock
Biogen Inc's (BIIB) last reported annual revenue was USD 9.84 Billion.
Biogen Inc's (BIIB) annual revenue growth rate based on the revenue reported in the past 5 years is : -6.07%
Biogen Inc's(BIIB) is profitable as of its last reported annual financials.
The net profit margin for Biogen Inc's(BIIB) from its laster reported year is 11.81%
The return on equity (ROE) for Biogen Inc's(BIIB) from its last reported annual financials is : 8.24%
The return on assets (ROA) for Biogen Inc's(BIIB) from its last reported annual financials is : 4.58%
The return on invested capital (ROIC) for Biogen Inc's(BIIB) from its last reported annual financials is : 5.61%
The Debt to Equity ratio for Biogen Inc's(BIIB) from its last reported annual financials is : 45.87%
The dividend yield for Biogen Inc's(BIIB) from its laster reported year is 0.00%
Biogen Inc's(BIIB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIIB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
